FRONTIERS IN NEUROLOGY, cilt.9, 2018 (SCI-Expanded, Scopus)
Background: Blood levels of immune markers have been proposed to discriminate patients with Parkinson's disease (PD) from controls. However, differences between clinical PD subgroups regarding these markers still need to be identified.